Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,400 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
The Lancet Rheumatology, 2022Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study
Clark K., Csomor E., Campochiaro C. et al.
Olink Target 96
Molecular Metabolism, 2022Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolism
Ho M., Zhang C., Moon I. et al.
Journal of Neuroendocrinology, 2022Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors
Thiis‐Evensen E., Kjellman M., Knigge U. et al.
International Journal of Cardiology, 2022Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study)
de Lange I., Petersen T., de Bakker M. et al.
Molecular Psychiatry, 2022Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study
Sandberg J., Hansson C., Göteson A. et al.
British Journal of Haematology, 2022A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease
Pratta M., Paczesny S., Socie G. et al.
Annals of Oncology, 2022Impact of acetaminophen on the efficacy of immunotherapy in cancer patients
Bessede A., Marabelle A., Guégan J. et al.
Osteoporosis International, 2022Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial
Sköld C., Kultima K., Freyhult E. et al.
PLOS ONE, 2022Genetically regulated gene expression and proteins revealed discordant effects
Pott J., Garcia T., Hauck S. et al.
European Journal of Heart Failure, 2022Distinct pathophysiological pathways in women and men with heart failure
Ravera A., Santema B., de Boer R. et al.
Scientific Reports, 2022Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction
Girerd N., Cleland J., Anker S. et al.
Allergy, 2022T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID‐19
Taeschler P., Adamo S., Deng Y. et al.
Nature Communications, 2022Genetic analyses identify pleiotropy and causality for blood proteins and highlight Wnt/β-catenin signalling in migraine
Tanha H., Nyholt D., Nyholt D.,
Clinical and Translational Medicine, 2022Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
García‐Hidalgo M., González J., Benítez I. et al.
The Journal of Infectious Diseases, 2022Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy
Kolossváry M., deFilippi C., Lu M. et al.
Cell Reports Medicine, 2022TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies
van der Ploeg K., Kirosingh A., Mori D. et al.
American Journal of Respiratory Cell and Molecular Biology, 2022Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform
Mickael C., Kheyfets V., Langouët-Astrié C. et al.
Frontiers in Aging Neuroscience, 2022The Roles of Long-Term Hyperhomocysteinemia and Micronutrient Supplementation in the AppNL–G–F Model of Alzheimer’s Disease
Nieraad H., de Bruin N., Arne O. et al.
Olink Target 96 Mouse
Experimental Dermatology, 2022Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris
Koschitzky M., Navrazhina K., Garshick M. et al.
Translational Neurodegeneration, 2022Advances in the development of new biomarkers for Alzheimer’s disease
Klyucherev T., Olszewski P., Shalimova A. et al.
3478 publications
Items per page
661-680 of 3478 publications